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ttp://dx.doi.org/10.1016/j.ajpath.2012.10.020Defects in urothelial integrity resulting in leakage and activation of underlying sensory nerves are
potential causative factors of bladder pain syndrome, a clinical syndrome of pelvic pain and urinary
urgency/frequency in the absence of a speciﬁc cause. Herein, we identiﬁed the microRNA miR-199a-5p
as an important regulator of intercellular junctions. On overexpression in urothelial cells, it impairs
correct tight junction formation and leads to increased permeability. miR-199a-5p directly targets
mRNAs encoding LIN7C, ARHGAP12, PALS1, RND1, and PVRL1 and attenuates their expression levels to
a similar extent. Using laser microdissection, we showed that miR-199a-5p is predominantly expressed
in bladder smooth muscle but that it is also detected in mature bladder urothelium and primary
urothelial cultures. In the urothelium, its expression can be up-regulated after activation of cAMP
signaling pathways. While validating miR-199a-5p targets, we delineated novel functions of LIN7C and
ARHGAP12 in urothelial integrity and conﬁrmed the essential role of PALS1 in establishing and
maintaining urothelial polarity and junction assembly. The present results point to a possible link
between miR-199a-5p expression and the control of urothelial permeability in bladder pain syndrome.
Up-regulation of miR-199a-5p and concomitant down-regulation of its multiple targets might be
detrimental to the establishment of a tight urothelial barrier, leading to chronic pain. (Am J Pathol
2013, 182: 431e448; http://dx.doi.org/10.1016/j.ajpath.2012.10.020)Supported by the Swiss National Science Foundation (SNF) grants
320030_135783/1 (K.M.), 3100A0_121980/1 (E.B.B.), and 320030_128064
(A.D.). V.S.-F. was a holder of SNF postdoctoral fellowship PBBEP3_129803.The bladder urothelium (UE) forms a lining of the urinary
tract, separating the urinary reservoir from the underlying
tissues and preventing the entry of noxious substances and
pathogens. Apart from being just a passive barrier, it plays
an important role in the sensory function of the bladder.1
The structure of the UE is highly specialized, reﬂecting
its ability to integrate mechanical and sensory input during
bladder ﬁlling and to transmit this information to the
connective tissue, nerves, and muscle layers. To adjust to
the changing bladder volume during ﬁlling and micturition,
the UE is stratiﬁed and ranges from four or ﬁve cells thick
when the urinary bladder is empty to two or three cells thick
when it is distended.2 The uppermost umbrella cell layer is
formed by large polyhedral cells interconnected by tight and
adherens junctions (TJs and AJs, respectively). TJ and AJ
proteins of the umbrella cells regulate urothelial perme-
ability, and their presence, amount, and distribution arestigative Pathology.
.the key factors determining the degree of tightness.3
The umbrella cells forming the upper layer have trans-
epithelial electrical resistance (TER) of >300,000 Ucm2,
making the UE one of the tightest epithelia of the body.4
In addition, the bladder is coated with a thin mucinous
layer composed of sulfonated glycosaminoglycans and
glycoproteins.5
The integrity of the UE is indispensable for the healthy
bladder.6 Mechanical or chemical damage, and bacterial
infection, can lead to a compromised UE, allowing urine to
penetrate into the interstitium.7 Epithelial dysfunction
resulting in a leaky UE has been suggested as a possible
cause of bladder pain syndrome (BPS)/interstitial cystitis
Monastyrskaya et al(IC), a clinical syndrome of pelvic pain, nocturia, and/or
urinary urgency/frequency in the absence of a speciﬁc
cause.8 The loss of epithelial integrity is a predominant
histopathologic ﬁnding in biopsy samples from patients with
BPS.9 In patients with BPS, the molecular markers for
bladder permeability and proteoglycan core proteins have
been shown to be down-regulated.10 Increased permeability
and decreased TJ formation has been observed in bladder
urothelial monolayers grown from biopsy samples from
patients with IC compared with controls.11 Therefore, it
seems possible that urothelial damage is a preceding feature
of this disorder and might be a causative factor in the
pathogenesis of BPS. Recently, we showed that mRNA
levels of the TJ proteins ZO-1, JAM-1, occludin, and tight
claudins, normally present in water-impermeable epithelia
and abundant in normal UE, were signiﬁcantly down-
regulated in bladder biopsy samples from patients with
BPS, indicating a compromised TJ structure and possibly
increased permeability of the UE.12
MicroRNAs (miRNAs) are quickly gaining recognition
for their role in many biologic processes and disease
states.13,14 miRNAs are endogenous noncoding single-
stranded RNAs of approximately 22 nucleotides that regulate
gene expression by posttranscriptional mechanisms following
sequence-speciﬁc binding to the 30 untranslated regions
(30UTRs) of their mRNA targets.13,15 miRNAs exhibit imper-
fect complementarity with mRNAs, allowing them to regulate
multiple genes and, thus, complicating efforts to predict and
functionally validate their targets.16
miRNAs play an important role in the regulation of
cell adhesion and cell migration17,18: a subset of miRNAs,
including miR-17, miR-29, miR-124, and miR-200, modu-
late cell adhesion pathways by controlling the expression
levels of cytoskeletal regulatory proteins and cell-cell
and cell-matrix adhesion molecules. The role of miRNAs
in TJ formation is less well-established, although there is
evidence that miR-212 inﬂuences intestinal permeability by
interfering with ZO-1 protein in Caco-2 cells,19 and tumor
necrosis factor aeinduced miR-122a causes degradation
of occludin in enterocytes and increases epithelial perme-
ability.20 In patients with irritable bowel syndrome, miR-29a
was increased, leading to a concomitant decrease of gluta-
mine synthetase levels and directly inﬂuencing intestinal
permeability through glutamine-dependent signaling
pathways.21
To identify the miRNAs inﬂuencing urothelial perme-
ability, we used an immortalized human ureteral cell line,
TEU-2, expressing ZO-1, occludin, JAM-1, and claudins 1,
2, 4, and 8 on differentiation into a multilayered culture.22,23
Taking 500 Ucm2 as a reference,4 we performed TER
measurements in differentiating TEU-2 cells transfected with
selected pre-miRNAs previously shown to be up-regulated in
patients with BPS.12 Herein, we show for the ﬁrst time, to our
knowledge, that miRNA expression inﬂuences urothelial
permeability and might underlie the changes in the bladder
UE observed in BPS.432Materials and Methods
Reagents and Antibodies
Polyclonal antibodies against claudin 1 (catalog No.
51-9000), occludin (catalog No. 71-1500), JAM-1 (catalog
No. 36-1700), and Velis (MALS-3 or LIN7C) (catalog No.
51-5600) were from Invitrogen (Carlsbad, CA). Monoclonal
anti-PALS1 (G-5) antibody (sc-365411) was from Santa
Cruz Biotechnology (Santa Cruz, CA). Alexa Fluor
488elabeled phalloidin was from Molecular Probes (Invi-
trogen). Restriction endonucleases, Taq polymerase, and T4
DNA ligase were purchased from New England Biolabs
(Ipswich, MA). Pre-miR miRNA precursors and validated
small-interfering RNAs (siRNAs) were from Ambion
(Applied Biosystems, Foster City, CA). Chemicals were
from Sigma-Aldrich (St. Louis, MO).
Patients
Permission to conduct this study was obtained from the
Ethics Committee of the Canton of Bern (KEK 146/05), and
all the participants gave written informed consent. Patient
selection and evaluation was described previously.12
Patients were divided into two groups: the control group
consisted of asymptomatic patients undergoing cystoscopy
for other reasons (eg, stent placement for stone disease or
microhematuria evaluation), and the BPS group consisted of
patients with pain (for >3 months) considered to be located
in the bladder and/or frequency, urgency, and nocturia.
Cold cup biopsy samples from the bladder dome were
collected from 8 controls and 28 patients with BPS in
a previously published study.12 All the patients with BPS had
bladder pain for >3 months, accompanied by frequency,
urgency, or nocturia. No patient had an increased postvoid
residual. Urodynamic studies showed a median cystometric
bladder volume of 200 mL (range, 60 to 1000 mL). One
patient had a high-capacity bladder with a volume>1000 mL,
and two patients had a normal capacity; the remaining patients
had low-capacity bladders. Histopathologic evaluation showed
chronic inﬂammation (lymphoplasmocytic inﬁltration, inter-
stitial edema, and/or hyperemia of the blood vessels with
dilated lumina) in all but 4 patients, and 17 demonstrated
increased mast cells in smooth muscle (SM) (20/mm2). The
samples were processed and evaluated by quantitative real-time
PCR (qPCR) as described previously.24 For morphologic
studies, samples from the dome were obtained from four
patients (three women and one man; mean age, 65 years; age
range, 52e74 years) undergoing radical cystectomy for
bladder cancer who had no lower urinary tract symptoms aside
from hematuria. The samples localized well away from the
tumor.
Cell Culture and Transfection
The immortalized human urothelial cell line TEU-223 was
maintained in serum-free EpiLife medium supplementedajp.amjpathol.org - The American Journal of Pathology
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otics (Cascade Biologics, Portland, OR). Differentiation of
TEU-2 cells was achieved by the addition of serum and
Ca2þ as previously described.22 For TER measurements,
the cells were cultured in 12-well plates with inserts (BD
Falcon, Franklin Lakes, NJ). Pre-miR miRNA precursors
for miR-199a-5p, miR-320a, and miR-328 and a validated
Cy3-labeled negative control were from Ambion (Applied
Biosystems). The reverse transfections were performed in
12-well plates with and without inserts using Lipofect-
amine 2000 reagent (Invitrogen) or siPORT NeoFX
transfection agent (Applied Biosystems). The transfected
cells were incubated at 37C for 24, 48, or 72 hours
before TER measurements and mRNA isolation.
HEK293 cells were maintained in Dulbecco’s modiﬁed
Eagle’s medium containing 2 mmol/L glutamine, 100 U/mL
of penicillin, 100 mg/mL of streptomycin, and 10% fetal calf
serum. HEK293 cells were transiently transfected with
reporter plasmids and pre-miR miRNA precursors using
Lipofectamine 2000 reagent (Invitrogen) and were assayed
for luciferase activity 24 hours after transfection.
The immortalized human bronchial epithelial cell line
16HBE14o- was a gift from Prof. Dieter Gruenert (University
of California at San Francisco, San Francisco, CA). The cells
were cultured on CELLþ-coated Petri dishes (Sarstedt Inc.,
Newton, NC) in minimal essential medium containing 2
mmol/L glutamine, 100 U/mL of penicillin, 100 mg/mL of
streptomycin, and 10% fetal calf serum and were transfected
with pre-miR miRNA precursors using Lipofectamine 2000
reagent (Invitrogen).
Primary cultures of human bladder UE were established
and maintained in CnT-18 medium (CELLnTEC, Bern,
Switzerland) as described previously.12 For differentiation,
the UE cells were grown on 0.4-mm-pore inserts (BD
Falcon) and were induced by incubating in CnT-21 medium
supplemented with 2 mmol/L Ca2þ and 10% fetal calf
serum. All the cell cultures were incubated at 37C, 85%
humidity, and 5% CO2. Cell proliferation and metabolic
activity was assessed using alamarBlue reagent (Invitrogen)
following the manufacturer’s instructions.
TER Measurements
Cells were cultured in 0.4-mm-pore inserts (BD Falcon). TER
was measured using the Millicell-ERS device (Millipore,
Billerica, MA). For each insert, TER was measured in four
equidistant locations, and an average of the fourmeasurements
taken as the TER value at the selected time point. The resis-
tance values are presented as unit area resistance (unit area
resistanceZ TER  cm2Z Ucm2).
Immunoﬂuorescence Labeling
Cells grown on cell culture inserts with a 0.4-mm pore
size (BD Falcon) were ﬁxed with 4% paraformadehyde,
permeabilized in 0.05% Triton X-100 in PBS, and incubatedThe American Journal of Pathology - ajp.amjpathol.orgwith the primary antibodies for 1 hour. Cells were washed
and incubated with the Cy3- or Alexa Fluor 488econjugated
secondary antibodies and DAPI stain. Inserts were mounted
in PBS-gelvatol and were examined using an Axiovert
200M microscope with laser scanning module LSM 510
META (Carl Zeiss MicroImaging GmbH, Jena, Germany).
Electron Microscopy
TEU-2 cells were cultured on 0.4-mm-pore inserts
(BD Falcon) either as monolayers or in differentiation
medium for 72 hours. The insert ﬁlters were cut out and
ﬁxed in 2.5% glutaraldehyde in Naþ cacodylate buffer and
were embedded in Epon 812 resin for electron microscopy
processing. Epon-embedded ultrathin sections were exam-
ined using a Zeiss 400 electron microscope (Carl Zeiss
MicroImaging GmbH).
Laser Microdissection
Bladder UE and SM cells were selectively isolated using
the PALM laser microdissection platform (Carl Zeiss
MicroImaging GmbH). Optimal cutting temperature com-
poundeembedded frozen bladder tissue was sectioned at
a thickness of 10 mm and was mounted onto PALM
membrane slides. The slides were stained using the Arcturus
HistoGene LCM frozen section staining kit (Life Technolo-
gies, Carlsbad, CA) according to the manufacturer’s
instructions. The PALM MicroBeam system was used to
obtain pure populations of either urothelial cells (collected
from the upper half of the normal bladder UE) or bladder SM
cells (collected from the detrusor muscle bundles) until at
least 10,000 cells were collected for each sample. The
microdissected cells were transferred to lysis buffer (provided
in the mirVana miRNA isolation kit; Ambion, Austin, TX)
for miRNA extraction.
Total RNA Isolation, Reverse Transcription, and Real-
Time PCR Analysis of mRNA and miRNA Expression
Total RNA was isolated using the mirVana miRNA isolation
kit (Ambion) as described previously.12,24 To separate the
bladder UE from the underlying stroma, postoperative tissue
was treated with 5 mg/mL of dispase II overnight at 4C.
The reverse transcription reactions were performed using
a high-capacity cDNA reverse transcription kit (Applied
Biosystems) with random hexamer primers. TaqMan primers
(occludin Hs00170162_m1, claudin 1 Hs00221623_m1,
JAM-1 Hs00170991_m1, 18S Hs99999901_s1, sirtuin 1
Hs01009006_m1, Rho GAP21 Hs00372683_m1, SRF
Hs00182371_m1, E-cadherin Hs00170423_m1, N-cadherin
Hs00169953_m1, ﬁbronectin Hs01549976_m1, vimentin
Hs0018584_m1, and Snail Hs00195591_m1) for real-time
qPCR were from Applied Biosystems. Quantiﬁcation of
maturemiR-199a-5p and endogenous control miRNARNU48
was performed using TaqMan assays 000498 and 001006with
supplied assay-speciﬁc RT primers (Applied Biosystems).433
Monastyrskaya et alTheexon junctionespanningprimers for SYBRgreenqPCR
were designed by using Primer-BLAST software (NCBI) and
were synthesized by Microsynth AG (Balgach, Switzerland).
The following primer pairs (forward and reverse) were used
(all based on human sequences): 28S rRNA (endogenous
control), 50-TCTGACTTAGAGGCGTTCAGTCATAAT-30
and 50-GTTGTTGCCATGGTAATCCTGCTCAGT-30; LIN7C,
50-GAGCGAACGCTACTGCAAAGGCTA-30 and 50-ATC-
TCCACGTTTGAGGCCCCCA-30; GEF12, 50-ATCACCGA-
CAGGTTTCCCCTCAA-30 and 50-TACGCAACGCTGAA-
CAAGACCAT-30; ARHGAP12, 50-CCAAAGCACCAAGA-
TACAGCCAGCA-30 and 50-GAACCCTGCAACACCGCC-
CAA-30; ARHGAP29, 50-CGAGATGGAGCGCCGTGGAT-
TTC-30 and 50-GTTGACCTGATGCCCAAGCACG-30; ROC-
K1, 50-GACTTTGGGCGTCCGAGCGG-30 and 50-CCAAA-
GCATCCAATCCATCCAGCAA-30; PALS1, 50-CTGCAG-
TTCCTCATACAACCCGGA-30 and 50-TCTG-CCTCGAAT-
GCTTGCCGC-30; RND1, 50-AGCGCACTC-AAGAAGTG-
GAGGAC-30 and 50-GCCTGCTTCTGGTGG-GACAGC-30;
PVRL1, 50-ATCACAGAATTCCCCTACA-CCCCG-30 and
50-CCCCCAATGATGGCCGTGGG-30; CLTC, 50-GCAG-
CACTGGGACTTGAGCGA-30 and 50-TGCAGCTCTTAG-
CACCTTGGGA-30; and PXN, 50-CAGGGCCTGGAGCAA-
AGAGCG-30 and 50-TTCCCCTGGGCCATGAACCCTC-30.
qPCR was performed in triplicate using the 7900HT fast
real-time PCR system (Applied Biosystems). The CT values
obtained after real-time qPCR were normalized to the 18S
rRNAwhen performing TaqMan qPCR and to the 28S rRNA
when performing SYBR green qPCR. CT values of miR-
199a-5p TaqMan assay were normalized to RNU48. The
end products of all PCR reactions were analyzed on a 4% low
melting point agarose gel to validate the fragment size.
Fireﬂy Luciferase Constructs and Luciferase Reporter
Assays
Luciferase reporter plasmids pSGG_3UTR containing
30UTRs of occludin, claudin 1, and JAM-1 (F11R) as well
as R01 negative control vector were purchased from
SwitchGear Genomics Inc. (Menlo Park, CA). The con-
structs were cotransfected with Renilla luciferase expression
vector pRenilla-TK-luc and pre-miR miRNA precursor
molecules or negative control miRNA precursors (Ambion).
Fireﬂy and Renilla luciferase assays were performed 24
hours after transfection using a dual-luciferase reporter
assay kit (Promega Corp., Madison, WI) according to the
manufacturer’s protocol. Fireﬂy luciferase activity was
normalized to Renilla expression for each sample.
30UTR sequences of human LIN7C and ARHGAP12
mRNAs containing putative miR-199a-5p binding sites
were PCR ampliﬁed from TEU-2 cDNA and cloned into
pmirGLO vector (Promega Corp.). For generation of
a reporter vector bearing a 2072-bp human LIN7C 30UTR
fragment with three putative miR-199a-5p binding sites, the
following primers were used: forward 50-AATAAGC-
TAGCTGGTGGTGGGAAGTAGCTGAAGCA-30; reverse43450-AATAACTCGAGGGCAAAGGGGGCAGAATGATG-
ACA-30 (Microsynth AG). For generation of a reporter
vector containing a 1148-bp human ARHGAP12 30UTR
fragment with a putative miR-199a-5p binding site, the
following primers were used: forward 50-ATAAACTCGA-
GGCTAGCGGGAAGGGGAGAGTCGAGATGTGTG-30;
reverse 50-ATAAACTCGAGTCTTCAACAGACCATGC-
TCCCTGTA-30 (Microsynth AG). NheI and XhoI restric-
tion sites are shown in italics. A pmirGLO vector containing
the miR-199a-5p target sequence 50-GAACAGGTAGTC-
TGAACACTGGG-30 was constructed and used as a posi-
tive control. A vector containing a mismatched sequence
(shown in italics), 50-GAACAGGTAGTCTGAACGGTAT-
G-30, was used to verify the speciﬁcity of miR binding, and
the empty pmirGLO vector was used as negative control.
Following the similar cloning strategy, putative miR-199a-
5p binding sites from the 30UTRsofARHGAP12: position 279,
50-TTCTAACCAGTCATATACACTGGA-30; ARHGAP12
mismatch (mutated nucleotides shown in bold), 50-TTC-
TAACCAGTCATATCATTGACA-30; LIN7C: 1182 site, 50-
AATATTTCATTTGTCCACTGGAT-30; 1527 site, 50-ATT-
AAGGTATTGAACACTGGA-30; and 2542 site, 50-TATAA-
AATGATCTGATTACACTGGA-30; PALS1 (alias MPP5):
position 1476, 50-ACCCAGAGCTAAACACTGGA-30;
RND1: position 71, 50-GATGAGACAATTTAGGACACT-
GGA-30; and PVRL1 (alias nectin 1): position 346, 50-
CTCCCCC-GCCCCCCTACACTGGA-30 were inserted as
linkers between NheI and XhoI sites of pmirGLO vector. To
detect luciferase activity, dual-luciferase reporter assay
(Promega Inc.) was used, and the activity was normalized to
Renilla luciferase expressed from the pmirGLO vector.
RhoA and Rac1 Activation Assays
In each assay, 2  106 TEU-2 cells were transfected with
pre-miR miRNA precursor for miR-199a-5p and a validated
Cy3-labeled negative control as described previously herein.
The 5  104 transfected cells were plated separately on cell
culture inserts with a 0.4-mm pore size (BD Falcon) to
control differentiation by TER, and the rest were cultured on
standard tissue culture dishes and induced to differentiate as
described previously herein. Seventy-two hours after
differentiation, cells were harvested and lysed in assay/
sample buffer (Cell Biolabs Inc., San Diego, CA), and
protein concentration was determined using the BCA
protein assay kit (Pierce Biotechnology, Rockford, IL). The
sample concentration was adjusted to 1 mg/mL to normalize
the amount of starting material, and RhoA and Rac1 activity
was determined using a small GTPase pull-down assay
(RhoA/Rac1/cdc42 activation assay combination kit; Cell
Biolabs Inc.), following the manufacturer’s instructions.
SDS-PAGE and Western Blot Analysis
Unless otherwise stated, all the procedures were performed
at 4C or on ice. The cell lysates were analyzed byajp.amjpathol.org - The American Journal of Pathology
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antibodies. Image analysis to estimate the protein content of
the individual bands after SDS-PAGE and Western blot
analysis was performed using a PowerLook 1120 scanner
and ImageQuant TL software version 2003 (Amersham
Biosciences Europe GmbH; Freiburg, Germany).
Lentivirus Production and Transduction of TEU-2 Cells
Total RNA was isolated from differentiated TEU-2 cells,
and cDNA was produced by reverse transcription with
random hexamer primers as described previously herein.
The coding sequence of LIN7C was PCR ampliﬁed using
forward primer 50-ATAAAGCTAGCATGGCGGCGCTA-
GGGGAA-30 and reverse primer 50-ATAAAGGATCCG-
GTCTGTTCCTGCGTTTTG-30. The coding sequence of
PALS1 was PCR ampliﬁed using forward primer 50-
ATAAAGCTAGCATGACAACATCCCATATGAATG-30
and reverse primer 50-ATAAAGGATCCCCTCAGCCAA-
GTGGATGGTAC-30. Cloning NheI and BamHI sites are
shown in italics. PCR fragmentswere inserted into pCDH-EF1-
T2A-copGFP vector (System Biosciences, Mountain View,
CA) to produce pCDH-LIN7C and pCDH-PALS1 lentiviral
vectors. The cloning vector without insert was used as a control
(pCDH-GFP). HEK293FT cells (System Biosciences) were
plated at 50% conﬂuency on 10-cm dishes andwere transfected
with 12 mg of each of the pCDH-based lentiviral vectors
[LIN7C, PALS1, and green ﬂuorescent protein (GFP)], 8 mg of
packaging pPAX2, and 4 mg of pMD2.G plasmids using
Lipofectamine 2000 reagent (Invitrogen) following the manu-
facturer’s instructions. Supernatant was collected 24 and 48
hours after transfection, ﬁltered through a 0.45-mm-pore
cellulose acetate ﬁlter (Millipore), and mixed with PEG-it virus
concentration solution (System Biosciences) overnight at 4C.
Viruses were precipitated at 1500  g at 4C the next day
and were resuspended in PBS. The number of transducing
infectious units of each stock was determined by infection of
293T cells followed by assessing the percentage of GFP-
positive cells by ﬂuorescence-activated cell sorting.
Subconﬂuent monolayers of nondifferentiated TEU-2
cells were transduced with recombinant lentiviral particles
using 5  106 transducing infectious units per 1  106 cells
in the presence of 8 mg/mL of polybrene (Sigma-Aldrich).Table 1 TJ Proteins Altered in BPS and Corresponding Targeting miRN
mRNA TargetScan MicroCosm
ZO-1 miR-23a, miR-23b
OCLN
JAM-1 miR-485-5p
CLD1
CLD2 miR-379, miR-328
*http://www.microrna.org/microrna/home.do.
CLD, claudin; JAM-1, junctional adhesion molecule 1; OCLN, occludin; ZO-1, zon
The American Journal of Pathology - ajp.amjpathol.orgTypically, 70% to 95% of cells were GFP positive 48 hours
after transduction. Transduced cells were propagated,
ﬂuorescence-activated cell sorting sorted, and used in TER
assays as described previously herein. For double protein
expression studies, TEU-2 cells were ﬁrst transduced with
PALS1 lentivirus, positive cells selected and subsequently
transduced with LIN7C lentivirus particles.
Statistical and Data Analysis
In patient studies, normality was deﬁned using Kolmogorov-
Smirnov and Shapiro-Wilk tests (P < 0.05). Statistically
signiﬁcant differences were determined using a U-test with
a set to 0.05 for genes not displaying a normal distribution and
a two-tailed t-test, preceded by aLevene test, witha set to 0.05
for genes with a normal distribution. The results of cell assays
were analyzed using one-way analysis of variance followed
by a Tukey multiple comparison test or a two-tailed t-test,
preceded by a Levene test. All the studies were performed
using SPSS version 17.0 (SPSS Inc., Chicago, IL).
Results
Bioinformatic Prediction of Potential Targets of the
miRNAs Up-Regulated in BPS
Higher urothelial permeability is one of the possible causes
of BPS.25,26 We used bioinformatics to determine whether
some of the miRNAs identiﬁed in the biopsy screen of
patients with BPS12 have TJ proteins as targets. The miR-
NAs miR-320a, miR-328, and miR-199a-5p were among
those predicted by the miRNA databases to have occludin,
JAM-1, or claudin 1 as target mRNAs (Table 1). These
miRNA levels were increased two to ﬁve times in BPS
biopsy samples12 and were selected for testing in the uro-
thelial permeability assays.
Differentiation of TEU-2 Cells Leads to the Formation
of TJs
The immortalized urothelial cell line TEU-223 was assessed
for its ability to form functioning TJs during differentiation.
When the cells were grown in serum-free proliferationAs Up- or Down-Regulated in the Patient Biopsy Samples
Database
microRNA.org*
miR-186, miR-27a, miR-23a, miR-511, miR-23b
miR-199a-5p, miR-320a
miR-493, miR-149, miR-182, miR-485-5p, miR-328, miR-199a-5p
miR-493, miR-186, miR-320a, miR-95, miR-597, miR-199a-5p,
miR-27a, let-7g, miR-182
miR-511, miR-95, miR-182, miR-485-5p, miR-328
ula occludens 1.
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Monastyrskaya et almedium, no TJs were formed as judged by the TER
measurements and immunoﬂuorescence staining: TER
values of these cultures remained at w150 Ucm2, occludin
and claudin 1 were retained in the cytoplasm, and abundant
stress ﬁbers were observed but a perijunctional actin ring was
not (Figure 1A). Incubation of TEU-2 in differentiation
medium containing 10% serum and 2 mmol/L Ca2þ led to an
increase in TER from w150 to >1000 Ucm2 and relocali-
zation of occludin to the cell-cell contacts (Figure 1B). The
formation of multilayered cultures with TJs between the
uppermost cells was conﬁrmed by electron microscopy
(Figure 1C). Serum-induced differentiation of TEU-2 cells
was accompanied by signiﬁcant up-regulation of occludin
mRNA levels when analyzed by qPCR (Figure 1D).
Ectopic Expression of miR-199a-5p Decreases TER in
TEU-2 and 16HBE14o- Cells
To address the role of miRNAs in TJ formation, non-
differentiated TEU-2 cells were transfected with pre-miR
miRNA precursors for miR-199a-5p, miR-320a, and
miR-328 or a validated Cy3-conjugated negative control.Figure 1 Differentiation of the urothelial cell line TEU-2 induces TJ formation
in serum-free medium for 72 hours. TER was measured every 24 hours, and the v
488elabeled phalloidin (actin stain, green) and anti-occludin (top panel) or anti-c
with DAPI. B: TEU-2 cells were grown on inserts and were stained with anti-occludi
of undifferentiated TEU-2, TER of 150 Ucm2. Bottom panel: TEU-2 after 72 hours
plasma membrane during TJ assembly. C: Electron micrographs of nondifferenti
indicate TJs; circles, desmosomes. D: mRNA levels of occludin (OCLN), JAM-1, an
TEU-2 monolayers, and 24, 48, and 72 hours after inducing differentiation. The
relative to the mean value for monolayer cultures. The graph shows the mean  S
the undifferentiated cells are indicated. *P < 0.05. Scale bars: 20 mm (A and B)
436Twenty-four hours after transfection, the cells grown on
0.4-mm-pore inserts were placed in the differentiation
medium, and TJ formation was monitored by TER measure-
ments. Although the cells transfected with negative control
miRNA and miR-320a and miR-328 did not show signiﬁcant
differences in TJ formation compared with the nontransfected
control, the expression of miR-199a-5p resulted in a signiﬁ-
cant (P < 0.01) decrease in TER (Figure 2A).
To determine whether miR-199a-5p affected cell growth
and proliferation, the transfected cells were counted at
the beginning and the end of each experiment, and prolif-
eration is expressed as a fold increase in the original
plating cell number. After 72 hours in differentiation
medium, there were no changes in the rates of proliferation of
miR-199a-5petransfected cells compared with the negative
control miR-Cy3etransfected cells or nontransfected control
(Figure 2B). Consequently, when cells were harvested in
equal volumes of lysis buffer and the protein concentration
was analyzed using BCA assay, no differences in the total
protein amount were observed (Figure 2C), indicating that
miR-199a-5p did not affect cell proliferation or growth.
Similarly, when the metabolic activity of control and. A: TEU-2 immortalized urothelial cells were cultured on 0.4mm pore inserts
alues did not exceed 150 Ucm2. Cells were double labeled with Alexa Fluor
laudin 1 (bottom panel) polyclonal antibodies (red). Nuclei were visualized
n antibody. Nuclei were visualized with DAPI. Top panel: Monolayer cultures
in differentiation medium, TER of 1200 Ucm2. Occludin translocates to the
ated (top panel) and differentiated (bottom panel) TEU-2 cells. Arrows
d claudin 1 (CLDN1) were determined by TaqMan qPCR in undifferentiated
results were normalized to 18S rRNA and are expressed as fold difference
EM of three experiments. Statistically signiﬁcant differences compared with
.
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Figure 2 Ectopic expression of miR-199a-5p in TEU-2 cells and 16HBE14o- cells reduces epithelial tightness. A: TEU-2 cells were transfected with pre-miR
precursors for miR-199a-5p, miR-320a, and miR-328 and with a validated Cy3-labeled negative control miR-Cy3. Twenty-four hours after transfection,
differentiation was induced by the addition of serum and Ca2þ, and TER was measured every 12 hours to monitor TJ formation. The graph shows the mean 
SEM of six experiments performed in duplicate. The tightness threshold (500 Ucm2) is indicated by a dotted line. Statistically signiﬁcant differences compared
with the nontransfected cells are indicated. B: Deﬁned numbers of TEU-2 cells were transfected with pre-miRs and were differentiated for 72 hours. Cells were
counted at the end of the differentiation time. The graph shows the mean  SEM of three experiments. C: Pre-miRetransfected and nontransfected cells were
differentiated and harvested from the inserts in an equal volume of lysis buffer, and the protein content of each sample was determined using BCA protein
assay. The graph shows the mean  SEM of three experiments. D: The immortalized human bronchial epithelial cell line 16HBE14o- was transfected with pre-
miR-199a-5p or scrambled negative control pre-miR-Cy3. Cells were cultured on 0.4 mm pore inserts, and TER was monitored every 24 hours. The graph shows
the mean  SEM of three experiments performed in duplicate. The tightness threshold (500 Ucm2) is indicated by a dotted line. Statistically signiﬁcant
differences compared with the nontransfected cells are indicated. *P < 0.01.
miR-199a-5p in Urothelial PermeabilitymiR-199a-5petransfected cells was assessed 72 hours after
differentiation using alamarBlue assay, no differences in the
rate of resazurin conversion to resoruﬁn were detected
(Supplemental Figure S1), indicating no signiﬁcant changes
in the metabolic activity.
Serum-induced differentiation of TEU-2 cultures poses an
additional level of complexity when addressing the role of
miRNAs in regulation of the urothelial permeability as serum
is a potent gene expression activator. To determine whether
the effects of miR-199a-5p on epithelial integrity were due to
its interference with the intercellular junctions or the serum-
responsive signaling cascades, we used the immortalized
human bronchial epithelial cell line 16HBE14o-27 for the
miRNA transfection assays. 16HBE14o- cells are normally
grown in serum-containing medium and establish TJs when
reaching an appropriate cell density.28 A signiﬁcant decrease
in TER was observed in 16HBE14o- cells transfected withThe American Journal of Pathology - ajp.amjpathol.orgmiR-199a-5p (Figure 2D), indicating weakened intercellular
junctions.
Expression of miR-199a-5p in Differentiating TEU-2
Cells Delays TJ Assembly
To assess the morphologic changes caused by miR-199a-5p
expression, we analyzed the distribution of selected TJ
proteins and actin in transfected TEU-2 cells. After 72
hours in differentiation medium, the controls typically
showed TER values of w1200 Ucm2 and occludin and
claudin 1 located at the plasma membrane in cell-cell contacts.
The actin cytoskeleton in these cells co-localized with
intercellular junctions, forming a ﬁlament ring (Figure 3, A
and C). In contrast, there was a signiﬁcant redistribution of
the junctional components in miR-199a-5peexpressing
cells (TER, 200 Ucm2); we observed weaker occludin437
Monastyrskaya et alstaining in the apical areas of the transfected cells
(Figure 3B) and intracellular retention of claudin 1, which
was present in the perinuclear endosomal compartment
(Figure 3D). The miR-transfected cells exhibited a thinner
epithelium with a less pronounced multilayer structure and
ﬂatter nuclei, resembling the undifferentiated TEU-2 cells
(Figure 3, E and F).Figure 3 miR-199a-5p interferes with TJ assembly in differentiating TEU-2 cell
immunoﬂuorescence labeling. Nontransfected TEU-2 cells (control; A and C) and
while monitoring TER. Cells were double labeled with Alexa Fluor 488elabeled phal
Apical and basal optical slices are shown. E and F: Multilayer formation and morph
pre-miR199a-5petransfected TEU-2 cells (F) were stained with Alexa Fluor 488ela
by laser scanning microscopy. The orthogonal projection view is shown. Scale ba
438miR-199a-5p Decreases mRNA and Protein Levels of
LIN7C, PALS1, PVRL1, ARHGAP12, and RND1 in TEU-2
Cells
Although mammalian miRNAs exhibit imperfect seed
sequence complementarity, they can effectively down-
regulate the mRNA levels of their targets by deadenylations. AeD: Expression and localization of TJ markers and actin were studied by
miR-199a-5peexpressing cells (B and D) were differentiated for 72 hours
loidin (actin, green) and occludin (A and B; red) or claudin 1 (C and D; red).
ologic features were assessed by confocal microscopy. Control cells (E) and
beled phalloidin and DAPI 72 hours after differentiation and were analyzed
rs: 20 mm.
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miR-199a-5p in Urothelial Permeabilityand exonucleolytic attack.13,29 We used qPCR to monitor the
levels of mRNA encoding several proteins involved in TJ
formation or regulation of actin dynamics based on miR-
199a-5p target predictions in the TargetScan 6.1, Micro-
Cosm Targets version 5, and microRNA.org databases.
We did not detect signiﬁcant changes in mRNA levels of
sirtuin 1, previously described as miR-199a-5p target in
cardiomyocytes,30 or serum response factor, but some
down-regulating trend in mRNA levels of ARHGAP21
(Supplemental Figure S2). TJ proteins JAM-1, claudin 1, and
occludin as well as the Rho-GTPase activator ARHGEF12
and ROCK1 were not affected; however, concomitant with
the decreased epithelial resistance, there was signiﬁcant
down-regulation of the mRNA levels of LIN7C and ARH-
GAP12 in transfected TEU-2 cells (Figure 4A).
These ﬁndings were conﬁrmed at the protein level: miR-
199a-5p caused down-regulation of LIN7C protein levels to
50% of the control (Figure 4B), whereas the protein levels
of occludin, claudin 1, and JAM-1 remained unchanged.
Consequently, there was no reduction of luciferase activity
in the assays performed using the 30UTRs of occludin,
JAM-1, or claudin 1 (data not shown). Unavailability of
a commercial antibody against ARHGAP12 has prevented
us from investigating its protein levels in miR-199a-
5petransfected cells.
Based on the miRNA target prediction (microRNA.org
and TargetScan 6.1), we extended the search of miR-
199a-5peregulated genes by examining the mRNA levels
of PALS1 (MPP5), RND1, PVRL1, paxillin (PXN), and
clathrin heavy chain in miR-transfected TEU-2 cells. We
observed signiﬁcant down-regulation of PALS1, RND1, and
PVRL1 mRNAs (Figure 4C). PALS1 is an important
regulator of TJ and AJ formation and epithelial polarity,31
and we further characterized its expression at the protein
level using speciﬁc antibodies. We observed signiﬁcant
down-regulation of PALS1 protein levels in miR-199a-
5peexpressing TEU-2 cells (Figure 4D).30UTRs of LIN7C, ARHGAP12, PALS1, RND1, and PVRL1
Harbor miRNA Binding Sites that Are Directly Targeted
by miR-199a-5p in Luciferase Assay
There are three potential miR-199a-5p binding sites in the
30UTR of LIN7C and one in the 30UTR of ARHGAP12
(microRNA.org). A direct interaction between miR-199a-
5p and LIN7C and ARHGAP12 30UTR was conﬁrmed
by reduced luciferase activity in HEK293 cells cotrans-
fected with pmirGLO-30UTR constructs and miR-199a-5p
(Figure 5A). Although the exact copy of this miRNA’s
binding sequence reduced luciferase activity to w5% of
the control level, pmir-30UTR-LIN7C and pmir-30UTR-
ARHGAP12 down-regulated its activity to 50% and 60%
of the control, respectively, which correlated well with the
mRNA level reduction observed in transfected TEU-2 cells
(compare Figure 5A with Figure 4, A and B). Mutation ofThe American Journal of Pathology - ajp.amjpathol.orgthe target sequence resulted in the loss of luciferase
activity inhibition, conﬁrming the speciﬁcity of the
interaction.
ARHGAP12 has a single putative miR-199a-5p binding
site (shown in italics): 5-0UUCUAACCAGUCAUAU-
ACACUGGA-30 at position 279 of its 30UTR. The construct
pmirGLO-GAP12site, containing this sequence, displayed
approximately 70% of the luciferase activity compared with
the no insert control (Figure 5B), whereas a mutation of ﬁve
nucleotides in the binding sequence (pmirGLO-GAP12site
mismatch) abolished the miR-199a-5pemediated inhibition
(Figure 5B). These results indicate that miR-199a-5p inter-
acted with the predicted miRNA binding site in the 30UTR
of ARHGAP12 and reduced its expression levels.
LIN7C has three putative miR-199a-5p binding sites
(shown in italics), at positions 1182 (50-AAUAUUU-
CAUUUGUCCACUGGAU-3), 1527 (50-AUUAAGGUAU-
UGAACACUGGA-30), and 2542 (50-UAUAAAAUGAU-
CUGAUUACACUGGA-30) of its 30UTR. Cloning these
sites individually into pmirGLO vector had a much weaker
inhibitory effect than the 30UTR fragment containing all
three sites (Figure 5C): only the LIN7C 1182 site caused
a 20% reduction in luciferase activity. However, combining
the sequences of 1182 and 1527 binding sites reduced
luciferase activity to 60% of the control, and all three
binding sites linked together further enhanced the luciferase
destabilization by miR-199a-5p, bringing its expression
levels to 40% of the control (Figure 5C). These data indicate
that all miRNA binding sites contribute to the LIN7C down-
regulation by miR-199a-5p.
Having established that miRNA binding sites have
a similar attenuating effect as the whole 30UTR, we pro-
ceeded to clone the putative miR-199a-5p binding sites of
PALS1, RND1, and PVRL1 into pmirGLO vector and
investigated their interaction with miRNA in luciferase
assays. A signiﬁcant inhibition of luciferase activity in all
constructs indicated direct regulation of PALS1, RND1, and
PVRL1 expression by miR-199a-5p (Figure 5D).Knockdown of LIN7C, ARHGAP12, and PALS1 Using
siRNAs Leads to TJ Assembly Defects
Having identiﬁed multiple junctional proteins as targets
of miR-199a-5p, we addressed their role in urothelial
permeability using gene expression knockdown with
speciﬁc siRNAs. A validated LIN7C siRNA effectively
down-regulated its protein levels in TEU-2 cells
(Figure 6A). siRNA-mediated knockdown of LIN7C in
differentiating TEU-2 cells caused a signiﬁcant decrease in
TER compared with the control; however, these effects
were less pronounced than those of pre-miR-199a-5p,
which essentially prevented TJ formation (Figure 6B). In
16HBE14o- cells, LIN7C siRNA effectively reduced its
protein levels but had no effect on epithelial permeability
(data not shown).439
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Figure 4 miR-199a-5p down-regulates expression levels of LIN7C, PALS1, ARHGAP12, PVRL1, and RND1. A: The TEU-2 cells transfected with pre-miR-199a-
5p and negative control miR-Cy3 were grown on inserts, and TJ formation was monitored by TER measurements. mRNA levels were analyzed by SYBR green qPCR
and normalized to 28S rRNA and are expressed as fold difference relative to the mean values for miR-Cy3 cultures. The graph shows the mean  SEM of four
experiments performed in triplicate. Statistically signiﬁcant differences compared with the negative control are indicated. B: Pre-miRetransfected cells were
differentiated for 72 hours, harvested from the inserts in an equal volume of lysis buffer, and analyzed by SDS-PAGE under equal loading conditions, followed
by Western blot analysis with antibodies as speciﬁed. The results of a representative experiment performed in triplicate are shown. The protein levels detected
by Western blot analysis were quantiﬁed as described in Materials and Methods. The graph shows the mean  SEM of three experiments performed in triplicate.
Statistically signiﬁcant differences compared with the negative control are indicated. C: mRNA levels of PALS1 (MPP5), RND1, PVRL1, PXN, and clathrin heavy
chain (CLTC) were analyzed by qPCR after TEU-2 cell transfection with pre-miR-199a-5p and negative control miR-Cy3. The values were normalized by 28S rRNA
and are expressed as fold difference relative to the mean values for miR-Cy3 cultures. The graph shows the mean  SEM of three experiments performed in
triplicate. Statistically signiﬁcant differences compared with the negative control are indicated. D: The pre-miR-199a-5e and negative control miR-
Cy3etransfected cell lysates were analyzed by SDS-PAGE under equal loading conditions followed by Western blot analysis with anti-PALS1 antibodies as
speciﬁed. The protein levels were quantiﬁed as described in Materials and Methods. The graph shows the mean  SEM of three experiments. Statistically
signiﬁcant differences compared with the negative control are indicated. *P < 0.01. c, nontransfected cells, miR, pre-miR-199a-5petransfected cells.
Monastyrskaya et alARHGAP12-speciﬁc siRNA reduced the mRNA levels
of ARHGAP12 by 50% (Figure 6C). Selective down-
regulation of ARHGAP12 resulted in a delayed TER
increase in differentiating TEU-2 cells (Figure 6D). Impor-
tantly, there was a cumulative effect when cotransfecting
siRNAs against LIN7C and ARHGAP12: their combination440reduced TER signiﬁcantly stronger than the individual
siRNAs, approaching the values observed in pre-miR-199a-
5petransfected cells (Figure 6E).
In accordance with previously published results in
MDCK cells,32 siRNA-mediated knockdown of PALS1 in
TEU-2 cells effectively prevented TJ formation and TERajp.amjpathol.org - The American Journal of Pathology
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Figure 5 30UTRs of LIN7C, ARHGAP12, PALS1, PVRL1, and RND1 contain miR-199a-5p binding sites. A: 30UTR sequences of ARHGAP12 (GAP30UTR) and
LIN7C (LIN30UTR), as well as the perfectly complementary binding site for miR-199a-5p (target) and its mutated analog (mismatch), were cloned into pmirGLO
luciferase reporter vector, and luciferase activity assays were performed as described in Materials and Methods. Renilla luciferase activity expressed from the
same vector was used for normalization, and the data are expressed relative to the negative control miR-Cy3 transfections. B: A 24-bp sequence corresponding
to the single miR-199a-5p putative binding site within the 30UTR of ARHGAP12 (GAP12site) or its mutated version (GAP12site mismatch) were cloned into
pmirGLO luciferase reporter vector, and luciferase activity assays were performed after pre-miR-199a-5p and negative control transfection. C: Three putative
miR-199a-5p binding sites identiﬁed within the 30UTR of LIN7C were cloned separately or in combination into pmirGLO vector, and luciferase activity assays
were performed. D: The putative miR-199a-5p binding sites identiﬁed within the 30UTR of PALS1, RND1, and PVRL1 were cloned into pmirGLO vector, and
luciferase activity assays were performed. All the graphs show the mean  SEM of three experiments performed in triplicate. Statistically signiﬁcant differences
compared with the vector without insert are indicated. *P < 0.01, **P < 0.05.
miR-199a-5p in Urothelial Permeabilityincrease during differentiation (Figure 7A). Similar effects
were observed in 16HBE14o- cells, where PALS1-speciﬁc
siRNA signiﬁcantly reduced TER values (Figure 7B).
Although TEU-2 cells transfected with individual
siRNAs did not display noticeable defects in TJ archi-
tecture, we observed cell ﬂattening, claudin 1 retention,
and reduced perijunctional actin assembly morphologi-
cally resembling the miR-199a-5peexpressing cells in
TEU-2 cells, cotransfected with PALS1- and LIN7C-
speciﬁc siRNAs (Figure 7C). These ﬁndings indicate
that a coordinated attenuation of several junctional
proteins might be important for TJ assembly delay.
The pleiotropic effects of miR-199a-5p during cell junc-
tion formation were conﬁrmed by rescue experiments with
its target proteins LIN7C and PALS1. TEU-2 cells wereThe American Journal of Pathology - ajp.amjpathol.orgstably transduced with lentiviruses, overexpressing the
coding sequences of each protein, and TER formation was
monitored in the presence of miR-199a-5p (Supplemental
Figure S3). Although up-regulation of LIN7C in miR-
199a-5petransfected cells has helped achieve the higher
TER values compared with the GFP-expressing control
(Supplemental Figure S3A), it did not restore the TJ
formation. Similarly, an increase in the PALS1 protein level
with a recombinant lentivirus showed an amelioration of
miR-199a-5p effects but did not completely rescue the
phenotype (Supplemental Figure S3B). The coexpression
experiments were inconclusive because the cells transduced
with LIN7C and PALS1 lentiviruses did not establish
TJs (TER <500 Ucm2 in controls after 96 hours of
differentiation).441
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Figure 6 siRNA-mediated knockdown of LIN7C
and ARHGAP12 reduces epithelial tightness in
TEU-2 cells. A: TEU-2 cells were transfected with
negative control miR-Cy3, siRNA against LIN7C, or
pre-miR-199a-5p, and LIN7C protein levels were
analyzed by Western blot analysis (inset) followed
by quantiﬁcation analysis as described in Materials
and Methods. The graph shows the mean  SEM of
three experiments performed in triplicate. Statisti-
cally signiﬁcant differences compared with the
negative control are indicated. B: TEU-2 cells were
left nontransfected, transfected with pre-miR-199a-
5p, scrambled negative control pre-miR-Cy3, or
LIN7C siRNA, and TER was monitored every 24 hours
during differentiation. The graph shows the mean
 SEM of three experiments performed in duplicate.
The tightness threshold (500 Ucm2) is indicated by
a dotted line. Statistically signiﬁcant differences
compared with the nontransfected cells are indi-
cated. C: ARHGAP12-speciﬁc siRNA signiﬁcantly
reduces mRNA levels of ARHGAP12 in transfected
TEU-2 cells. mRNA levels were analyzed by qPCR and
normalized to 28S rRNA and are expressed as fold
difference relative to the average values for
untransfected cultures. The graph shows the mean
 SEM of three experiments performed in triplicate.
D: Epithelial tightness in differentiating TEU-2 cells
was monitored after transfection with pre-miR-
199a-5p, scrambled negative control pre-miR-Cy3,
or ARHGAP12 siRNA. The graph shows the mean 
SEM of three experiments performed in duplicate.
The tightness threshold (500 Ucm2) is indicated by
a dotted line. Statistically signiﬁcant differences
compared with the nontransfected cells are indi-
cated. E: Cotransfection of siRNAs against LIN7C
and ARHGAP12 reduces TER signiﬁcantly stronger
than the individual siRNAs. The TER values 72 hours
after differentiation were related to the TER
observed for the nontransfected cells in the same
experiment. The graph shows the mean  SEM of
three experiments. Statistically signiﬁcant differ-
ences between individual and double siRNA trans-
fection are indicated. *P < 0.01, **P < 0.05.
Monastyrskaya et almiR-199a-5p Expression Does Not Affect the Basal
Levels of RhoA and Rac1
TJs and AJs are dynamic structures linked to actin cyto-
skeleton, and Rho/Ras-GTPases play a pivotal role in their
regulation. Changes in Rho/Rac/cdc42-mediated signaling
affect TJ assembly and permeability.33,34 Herein, we iden-
tiﬁed ARHGAP12, a negative regulator of Rac1 activity,
and RND1, which belongs to a family of constitutively
active Rho GTPases, among the targets of miR-199a-5p.
To determine whether the reduction of their levels
inﬂuences the activity of actin-organizing GTPases, we
examined the basal levels of RhoA and Rac1 in miR-199a-
5peexpressing cells (Figure 8). We detected no signiﬁcant
differences in the amount of activated RhoA (Figure 8A) or
Rac1 (Figure 8B) in the pull-down assay, indicating that442miR-199a-5p affects urothelial permeability via attenuation
of junctional protein expression rather than by perijunction
actin reorganization.LIN7C and ARHGAP12 Are Expressed in Human
Bladder, and Their mRNA Levels Are Reduced in
Patients with BPS
LIN7C is a small scaffolding protein important for main-
taining epithelial membrane polarity; it has been recently
identiﬁed as a component of TJs and AJs.35,36 Having
established the link between miR-199a-5p expression and
LIN7C down-regulation in the TEU-2 cell line, and having
demonstrated its importance for urothelial integrity using
speciﬁc siRNA, we sought to investigate LIN7C expressionajp.amjpathol.org - The American Journal of Pathology
Figure 7 siRNA-mediated knockdown of PALS1 reduces
TER in TEU-2 and 16HBE14o- cells and together with LIN7C
siRNA causes TJ assembly defects. PALS1-speciﬁc siRNA was
transfected into TEU-2 cells (A) or 16HBE14o- cells (B) in
parallel with pre-miR-199a-5p and Cy3-labeled negative
control. This siRNA effectively reduced PALS1 levels as seen by
Western blot analysis (A, inset) and signiﬁcantly reduced TER
in both cell lines compared with the negative control miR-Cy3.
C: Differentiating TEU-2 cells were transfected with PALS1 and
LIN7C siRNAs and were analyzed by immunoﬂuorescence
labeling with Alexa Fluor 488elabeled phalloidin (actin,
green) and claudin 1 (red). Apical and basal optical slices are
shown. *P < 0.01. Scale bars: 20 mm.
miR-199a-5p in Urothelial Permeabilityand localization in the human bladder. LIN7C protein
was readily detectable in protein extracts from the total
bladder samples and dispase-dissociated human UE by
Western blot analysis (Figure 9A).
We established the primary cultures of human bladder
UE and detected LIN7C predominantly in the cytoplasm of
the proliferating cells maintained in the serum-free medium
(Figure 9B) (TER, 140 Ucm2). Differentiation of human
urothelial primary cultures was induced, adapting a porcine
UE protocol.37 When TER reached 500 Ucm2, indicative
of TJ formation, the cells grown on inserts were analyzed
by immunoﬂuorescence staining using anti-LIN7C poly-
clonal antibody and Alexa Fluor 488econjugated phalloidin.
At this time point, LIN7C was detected at the plasma
membrane in the intercellular junctions, co-localizing with
perijunctional actin ring (Figure 9B) (TER, 500 Ucm2).
Immunoﬂuorescence labeling of differentiating TEU-2 cells
showed a similar distribution of LIN7C (Supplemental
Figure S4).
Using qPCR, we investigated the mRNA levels of LIN7C
and ARHGAP12 in bladder biopsy samples of 28 patients
with BPS compared with 8 controls. Although the mRNA
levels of PALS1, RND1, and PVRL1 remained unchanged in
all the patients (data not shown), there was a signiﬁcant
(P < 0.05) reduction in LIN7C levels in patients with BPS
(Figure 9C). Similarly, the mRNA levels of ARHGAP12
were down-regulated in biopsy samples from patients with
BPS (P < 0.01) (Figure 9D). The biopsy sample collection
protocol did not allow enough material to estimate LIN7CThe American Journal of Pathology - ajp.amjpathol.orgprotein levels in patients with BPS, which is a limitation of
this study. Nevertheless, we established a strong correlation
between miR-199a-5p, which was approximately two times
up-regulated in patients with BPS,12 and the down-regulation
of its validated target mRNAs, LIN7C and ARHGAP12.
miR-199a-5p Is Preferentially Expressed in Bladder SM
and Can Be Up-Regulated in the UE by cAMP Pathway
Activation
The plethora of epithelium-speciﬁc targets of miR-199a-5p
identiﬁed in this study has prompted us to investigate the
involvement of this miRNA in the regulation of epithelial-
mesenchymal transition (EMT). Using qPCR, we assayed the
mRNA levels of several EMT markers in miR-199a-
5petransfected TEU-2 cells. Except for ﬁbronectin, which
was approximately twofold up-regulated, there were no
signiﬁcant alterations in the expression levels of E-cadherin,
N-cadherin, vimentin, or Snail (Figure 10). Nevertheless,
considering that miR-199a-5p down-regulated several
proteins critical for establishing and maintaining urothelial
polarity and junctional tightness, we sought to investigate
its precise localization in bladder layers. Using qPCR assays
for maturemiR-199a-5p and the endogenous control RNU48,
we analyzed the levels of this miRNA in the samples of
dissociated bladder UE and SM and in UE and SM primary
cultures. We detected miR-199a-5p in dissociated UE
(mean  SEM DCT, 8.39  0.39; nZ 3) and SM (mean 
SEMDCT,0.24 0.17; nZ 3); however, its level in theUE443
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Figure 8 miR-199a-5p expression does not affect basal RhoA or Rac1
activity. The basal activities of RhoA and Rac1 were determined by pull-
down assay as described in Materials and Methods using the lysates of
TEU-2 cells transfected with pre-miR-199a-5p (miR) or validated Cy3-
labeled negative control (c). Insets: The starting amounts of RhoA and
Rac1 in the lysates before the pull-down are shown (total), as are RhoA and
Rac1 recovered after binding to Rhotekin RBD and PAK PBD beads,
respectively (activated). The graphs show the mean  standard deviation
quantiﬁcation of the Western blot analysis results (insets) for RhoA (A)
and Rac1 (B) activation assays.
Monastyrskaya et alconstituted amere 0.4%of that in SM (Figure 11A). Culturing
urothelial cells further reduced miR-199a-5p expression
levels, whereas there was less pronounced down-regulation in
SM cultures (Figure 11A).
Previously, we characterized the dispase II dissociation as
a reliable and selective method of urothelial isolation.38
Taking into account that the low levels of miR-199a-5p in
dissociated UE were further signiﬁcantly reduced during
culturing, we performed a laser microdissection analysis of444the bladder UE to eliminate the possibility of UE sample
contamination with stromal ﬁbroblasts or SM cells. In
microdissected preparations of the UE, we detected similar
levels of miR-199a-5p as in enzymatically dissociated UE
samples (mean  SEM DCT, 7.83  0.12; n Z 4), and its
expression level in the UE compared with SM was
approximately 0.3% (Figure 11B).
miR-199a-5p expression in cardiomyocytes can be up-
regulated by isoproterenol and forskolin treatments,30 and
the human UE expresses functional b2-adrenergic recep-
tors.39 qPCR analysis of primary UE cultures incubated with
10 mmol/L isoproterenol or 10 mmol/L forskolin for 24
hours showed up-regulation of miR-199a-5p expression
levels (Figure 11C). Similarly, in TEU-2 cells, which do not
synthesize this miRNA under normal conditions, exposure
to isoproterenol or forskolin induced detectable levels of
miR-199a-5p (Figure 11D).Discussion
In this study, we identiﬁed miRNA miR-199a-5p as an
important regulator of urothelial integrity. On over-
expression in urothelial and bronchial epithelial cells, it
impairs correct TJ formation and leads to increased epithe-
lial permeability. Rather than regulating a single protein,
miR-199a-5p targets mRNAs encoding LIN7C, ARH-
GAP12, PALS1, RND1, and PVRL1 and attenuates their
expression levels to a similar extent.
LIN7C is a member of a group of small PDZ
domainecontaining scaffolding proteins (LIN2/LIN7/
LIN10) that are involved in TJ assembly and epithelial
polarization.40 LIN7C is a binding partner of PALS1
(protein associated with LIN7), which is necessary for
stabilization of epithelial polarity complexes: its knockdownFigure 9 LIN7C and ARHGAP12 are expressed in
the human bladder, and their mRNA levels are
decreased in patients with BPS. A: Human bladder
biopsy samples (Bl1 and Bl2) and dissociated human
UE were extracted with SDS sample buffer and were
analyzed by SDS-PAGE followed by Western blot ana-
lysis with anti-LIN7C polyclonal antibody. A 22-kDa
LIN7C protein band was detected in all the samples.
B: Primary cultures of the human UE were maintained
in proliferation medium (TER, 140 Ucm2) or were
induced to differentiate for 5 days (TER, 500 Ucm2)
before staining with anti-LIN7C polyclonal antibody
(red) and actin stain Alexa Fluor 488elabeled phal-
loidin (green). Scale bars: 20 mm. C: The mean  SEM
mRNA levels of LIN7C in bladder dome biopsy samples
(n Z 8, control group; n Z 28, BPS group). LIN7C
mRNA levels are signiﬁcantly down-regulated in
patients with BPS compared with controls. D: The
mean  SEM mRNA levels of ARHGAP12 in bladder
dome biopsy samples (nZ 8, control group; nZ 28,
BPS group). ARHGAP12 mRNA levels are signiﬁcantly
down-regulated in patients with BPS compared with
controls. *P < 0.05, **P < 0.01.
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Figure 10 Expression of EMT markers in pre-miR-199a-5petransfected
TEU-2 cells. TaqMan qPCR was used to study the mRNA levels of E-cadherin
(E-CDH), ﬁbronectin (FN), N-cadherin (N-CDH), vimentin (VIM), and Snail in
pre-miR-199a-5petransefcted and control TEU-2 cells. The results were
normalized to 18S rRNA and are expressed as fold difference relative to the
mean values for negative control miR-Cy3 cultures. The graph shows the
mean  SEM of three experiments. Statistically signiﬁcant differences
compared with miR-Cy3 negative control are indicated. *P < 0.01.
miR-199a-5p in Urothelial Permeabilityin MDCK cells caused delayed TJ formation.41 LIN7C is
recruited to AJs, where it interacts with b-catenin via PDZ-
binding C-terminal domain36 and associates with insulin
receptor substrate p53 localized to TJs.35
The present data indicate that the down-regulation of
LIN7C expression levels by miR-199a-5p or siRNA causes
profound defects in urothelial integrity: TEU-2 cells
depleted of LIN7C show signiﬁcantly decreased TER. In
contrast, 16HBE14o- cells did not display overt signs of TJ
destabilization, similar to earlier observations in MDCK
cells, which was attributed to LIN7C being important for the
formation rather than the maintenance of TJs.35,41 The
airway or renal epithelia do not undergo the profound
remodeling associated with bladder ﬁlling/emptying, and
the differential TJ/AJ regulation between these tissues might
reﬂect the differential physical requirements. We show that
LIN7C is highly expressed in the normal human UE, where
it co-localizes with the apical junctional complex during
differentiation. It is possible that the umbrella cells that are
continuously changing their size while maintaining TJs2,42
are more dependent on the scaffolding and actin cytoskeleton-
modulating function of LIN7C than on the bronchial or
kidney epithelia.
The Rho-GTPase activating protein ARHGAP12 is
another target of miR-199a-5p identiﬁed in this study.
ARHGAP12 is ubiquitously expressed43 and localizes to
AJs.44 ARHGAP12 displays GTPase activating activity
toward Rac1 and, on overexpression, impairs cell scattering,
invasion, and adhesion to ﬁbronectin in response to hepato-
cyte growth factor.45 The present study demonstrates that
suppression of ARHGAP12 bymiR-199a-5p and its selective
knockdown by siRNA contribute to the loss of urothelial
tightness in differentiating TEU-2 cells. We did not detect an
increase in basal Rac1 activity in the pre-miR-199a-
5petransfected TEU-2 cells, and it is possible that ARH-
GAP12 exerts its regulatory functions locally at the AJs.The American Journal of Pathology - ajp.amjpathol.orgPALS1 is a TJ protein essential for epithelial polarity,46
and its down-regulation causes profound defects in TJ32
and AJ47 formation, characterized by actin reorganization
and reduced TER. Herein, we show that PALS1 mRNA is
directly targeted by miR-199a-5p and, consequently, that
its protein level is decreased in miR-199a-5peexpressing
TEU-2 cells. In accordance with the previous studies, siRNA-
mediated knockdown of PALS1 in TEU-2 and 16HBE14o-
cells resulted in TER reduction, whereas knockdown of
PALS1 and its partner LIN7C delayed TJ protein assembly
similar to the ectopic expression of miR-199a-5p.
RND1 and PVRL1 mRNAs are the two further targets of
miR-199a-5p, identiﬁed in this study at the mRNA level and
validated in a luciferase assay. RND proteins are constitu-
tively active Rho-GTPases regulating actin cytoskeleton
and cell proliferation.48 RND1 is abundant in the brain,
liver, and SM.49 Its up-regulation causes a loss of stress
ﬁbers and cell rounding.50 We did not observe an increase in
RhoA activity in the miR-transfected TEU-2 cells, probably
because the level of RND1 is 20 times lower than that
of the ubiquitous nonattenuated RND3 (K.M., unpub-
lished observation, 2012). PVRL1 is an AJ protein involved
in the formation and stability of intercellular contacts,51 and
its involvement in urothelial differentiation and function
awaits further clariﬁcation.
The expression of miR-199a-5p in differentiating TEU-2
cells leads to claudin 1 retention, cell ﬂattening, delayed
formation of a multilayered epithelium, and the appearance
of stress ﬁbers. Pronounced stress ﬁbers and perinuclear
claudin 1 localization are characteristic of undifferentiated
TEU-2 cells. Considering that we did not detect signiﬁcant
alterations of basal RhoA or Rac1 activity after miR trans-
fection, it is possible that miR-199a-5p acts via a coordi-
nated attenuation of several TJ and AJ proteins and, thus,
delays epithelial polarization and junction assembly. The
notion of the pleiotropic effects of miR-199a-5p during
AJ/TJ formation is supported by the rescue experiments
with some of its target proteins. When TEU-2 cells were
stably transduced with lentiviruses, overexpressing the
coding sequences of LIN7C and PALS1 devoid of 30UTRs
and, thus, unaffected by miRNA, the resulting up-regulation
of their protein levels ameliorated but did not abolish the
miR-199a-5peinduced decrease in urothelial integrity.
Weakening of intercellular contacts is a hallmark of
EMT; however, this study did not detect signiﬁcant changes
in EMT marker expression in miR-transfected cells.
Nevertheless, speciﬁc inhibition of junctional proteins by
this miRNA prompted us to investigate its precise locali-
zation in the bladder layers. Using laser microdissection, we
showed that miR-199a-5p is predominantly expressed in
bladder SM but is detected in the mature bladder UE and in
primary UE cultures, albeit at much lower levels. Impor-
tantly, its expression in the UE can be signiﬁcantly
up-regulated after activation of b2-adrenergic receptors,
abundantly expressed in UE and TEU-2 cells, or cAMP
increase by forskolin.445
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Figure 11 miR-199a-5p is detected in the UE, is
abundant in bladder SM, and is up-regulated by cAMP
pathway activation. A: The UE was separated from the
stroma containing SM by an overnight dispase II
digestion and was used directly for RNA isolation or
was cultured as described in Materials and Methods.
Bladder SM cultures were used between passages 2
and 5. miRNA levels were determined by qPCR and
normalized to RNU48, and the levels in the cultures
are expressed as fold difference relative to the
dissociated samples. Mean  SEM DCT values are
shown above the respective bars of the graph (nZ 3).
B: UE and SM cells were recovered from the frozen
sections of the normal human bladder by PALM
microdissection, and the expression levels of miR-
199a-5p were studied by qPCR. Mean  SEM DCT
values (shown inside the graph) in the UE and SM
were normalized to the mean in bladder biopsy
samples. The end point PCR products were analyzed on
4% low melting point agarose gel (top). C: Primary UE
cultures were incubated with 10 mmol/L isoproterenol
(ISO) or 10 mmol/L forskolin (FORSK) for 24 hours, the
expression levels of miR-199a-5p studied by qPCR,
normalized to RNU48, and are shown as a fold
difference relative to the untreated samples (control).
The end point PCR products are shown (top). D: TEU-2
cells were incubated with 10 mmol/L isoproterenol
(ISO) or 10 mmol/L forskolin (FORSK) for 24 hours. The
expression levels of miR-199a-5p and RNU48 were
studied by PCR. Pre-miRe transfected cells (miRþve),
untreated nontransfected cells (c), and ISO and FORSK
treatments are shown. Equal amounts of RNU48 were
ampliﬁed an all the samples.
Monastyrskaya et alThis is the ﬁrst report, to our knowledge, describing
a regulatory function of miR-199a-5p in epithelial cells. This
miRNA was previously characterized in cardiomyocytes,
where it down-regulated hypoxia-inducible factor 1 alpha
and sirtuin 1.52 miR-199a-5p is up-regulated in cardiac
hypertrophy, and its overexpression in cardiomyocytes leads
to cell size increase.53 miR-199a is transcribed as antisense
to dynamin 3 on chromosome 1 (1q24.3), and hyper-
methylation of this region is associated with a reduction in
miR-199a-5p/3p and increased tumor malignancy in testic-
ular cancer.54 miR-199a-5p is decreased in most hepato-
cellular carcinoma tissue samples and cell lines,55 and
a separate study claims that in cultured cell lines, the
expression of miR-199a and miR-199a* is conﬁned to
ﬁbroblasts.56 These results are in agreement with the present
data, showing that in primary UE cultures and TEU-2 cells,
miR-199a-5p expression is quickly attenuated, whereas in
bladder SM cultures, its high expression levels are
maintained.446The mechanisms of up-regulation of miR-199a-5p in the
bladder during BPS are not completely understood. An
increase in miR-199a-5p levels in isoproterenol- or forskolin-
treated urothelial cells correlates well with earlier data
showing signiﬁcant up-regulation of b2-adrenergic receptors
in the bladder in BPS, concomitant with up-regulation of
miR-199a-5p.12 Stress is associated with symptom increase
in some patients with BPS/IC. Norepinephrine levels
were found to be elevated in urine from patients with IC
compared with urine from controls, consistent with increased
adrenergic activity from the bladders of patients with IC or
possibly from increased adrenal activity.57 It is possible that
increased adrenergic signaling during BPS might lead to
miR-199a-5p up-regulation and, consequently, affect uro-
thelial permeability. Herein, we demonstrate that the miR-
199a-5peregulated proteins LIN7C and ARHGAP12 are
decreased at the mRNA level in patients with BPS.
This study is the ﬁrst, to our knowledge, to link the
overexpression of an miRNA in the clinical condition ofajp.amjpathol.org - The American Journal of Pathology
miR-199a-5p in Urothelial PermeabilityBPS with the regulation of urothelial permeability. The
experimental validation of miRNA targets, performed herein
for miR-199a-5p, sheds new light on the regulatory processes
taking place during the disease and offers a potential direction
for future treatments.Acknowledgments
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